Scopus h-index
:
84
Article
:
200
Review Article
:
54
Comment/Debate
:
20
Letter
:
4
Editorial
:
2
Chapter
:
9
Recent Artifacts
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT–Stromal and Tgfb-Dependent Mechanisms
Strategies to overcome DC dysregulation in the tumor microenvironment
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer
Dark genome, bright ideas: Recent approaches to harness transposable elements in immunotherapies
Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer
View All Publications